ASX - By Stock
|
SQ2 |
Re:
DRS Statement
|
|
Equitable
|
60 |
18K |
0 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
60
|
18K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
14 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
iPPS and the engineering of tissue
|
|
Equitable
|
7 |
2.3K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
7
|
2.3K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Pure Play Opportunity
|
|
Equitable
|
63 |
22K |
38 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
63
|
22K
|
38
|
|
ASX - By Stock
|
SQ2 |
Re:
DRS Statement
|
|
Equitable
|
60 |
18K |
1 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
60
|
18K
|
1
|
|
ASX - By Stock
|
SQ2 |
Re:
APT to SQ2
|
|
Equitable
|
209 |
81K |
6 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
209
|
81K
|
6
|
|
ASX - By Stock
|
SQ2 |
Re:
APT to SQ2
|
|
Equitable
|
209 |
81K |
6 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
209
|
81K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR - Broker Data
|
|
Equitable
|
18 |
8.5K |
2 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
18
|
8.5K
|
2
|
|
ASX - By Stock
|
MKT |
Re:
THE MARKET HERALD LIMITED
|
|
Equitable
|
478 |
98K |
14 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
478
|
98K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
BRN at Virtual Investor Conference
|
|
Equitable
|
18 |
5.8K |
3 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
18
|
5.8K
|
3
|
|
ASX - By Stock
|
MKT |
Re:
THE MARKET HERALD LIMITED
|
|
Equitable
|
478 |
98K |
10 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
478
|
98K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
BRN at Virtual Investor Conference
|
|
Equitable
|
18 |
5.8K |
88 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
18
|
5.8K
|
88
|
|
ASX - By Stock
|
MKT |
Re:
THE MARKET HERALD LIMITED
|
|
Equitable
|
478 |
98K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
478
|
98K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
Equitable
|
179 |
50K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
11 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
11
|
|
ASX - By Stock
|
BRN |
Re:
Tony reply to the rubbish article
|
|
Equitable
|
61 |
18K |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
61
|
18K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
BRAINCHIP - Continues to IMPRESS the worldwide markets with it's NDA and ASX disclosures.
|
|
Equitable
|
179 |
50K |
9 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
179
|
50K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
5 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
15 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
15
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Equitable
|
339 |
137K |
5 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
339
|
137K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
35 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
35
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
13 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
13
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip Holdings outlines go-to market strategy for its neuromorphic artificial intelligence chips
|
|
Equitable
|
72 |
32K |
23 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
72
|
32K
|
23
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip Holdings outlines go-to market strategy for its neuromorphic artificial intelligence chips
|
|
Equitable
|
72 |
32K |
3 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
72
|
32K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip Holdings outlines go-to market strategy for its neuromorphic artificial intelligence chips
|
|
Equitable
|
72 |
32K |
9 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
72
|
32K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
Equitable
|
1.0K |
427K |
8 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
1.0K
|
427K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
10 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
10
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
2 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
35 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
35
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
29 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
29
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
64 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
64
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
16 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
16
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
35 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
35
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
11 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
11
|
|
ASX - By Stock
|
BRN |
Re:
5 Reasons Why Brainchip is Skyrocketing
|
|
Equitable
|
3 |
2.4K |
14 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
3
|
2.4K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
36 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
36
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
22 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
22
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
33 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
33
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
26 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
26
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
4 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
Charts
|
BRN |
Re:
Chart
|
|
Equitable
|
20K |
7.9M |
41 |
10/01/22 |
10/01/22 |
Charts
|
20K
|
7.9M
|
41
|
|
Charts
|
BRN |
Re:
Chart
|
|
Equitable
|
20K |
7.9M |
22 |
10/01/22 |
10/01/22 |
Charts
|
20K
|
7.9M
|
22
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Equitable
|
10K |
4.7M |
37 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
37
|
|
ASX - By Stock
|
BRN |
Re:
BRN $1 - READY FOR LIFT-OFF!!!!!!!!!!! YIKES....LAUNCHED ALREADY!!!!!!!!
|
|
Equitable
|
199 |
77K |
44 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
199
|
77K
|
44
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
Equitable
|
1.0K |
427K |
11 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.0K
|
427K
|
11
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
Equitable
|
1.0K |
427K |
57 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.0K
|
427K
|
57
|
|
ASX - By Stock
|
BRN |
Re:
Mercedes uses Akida
|
|
Equitable
|
1.0K |
427K |
34 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.0K
|
427K
|
34
|
|
ASX - By Stock
|
BRN |
Re:
2021 BRN Discussion
|
|
Equitable
|
33K |
11M |
25 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
33K
|
11M
|
25
|
|
ASX - By Stock
|
BRN |
Re:
TATA SNN patent
|
|
Equitable
|
95 |
42K |
19 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
95
|
42K
|
19
|
|
ASX - By Stock
|
BRN |
Re:
2021 BRN Discussion
|
|
Equitable
|
33K |
11M |
3 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
33K
|
11M
|
3
|
|